Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 6/2009

01.06.2009 | Original Article

Fetal macrosomia in African women: a study of 249 cases

verfasst von: C. I. Kamanu, S. Onwere, B. Chigbu, C. Aluka, O. Okoro, M. Obasi

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To determine the incidence and risk factors of macrosomia in a Nigerian centre, and to assess the relation of maternal body mass index (BMI) at birth and of the total weight gain during pregnancy to macrosomia and adverse pregnancy outcome.

Design

A retrospective review of fetal macrosomia over a 5-year period.

Setting

Abia State University Teaching Hospital, Aba in Southeast Nigeria.

Subjects

A total of 9,970 parturients managed from 1 January 1999 to 31 December 2003. Out of 249 documented cases of infants with birth weights ≥4,500 g, 240 (96.4%) maternal and neonatal records of macrosomia were available for review. Maternal and neonatal characteristics of the 240 cases were compared with 8,800 other parturients with singleton fetuses in vertex presentation.

Results

Macrosomic babies represented 2.5% of the infants delivered (249 of 9,970). Most of the mothers (92.5%) were multiparous. Maternal median weight gain was 11 kg (7–15), while the mean weight gain was 12.5 kg. Maternal median BMI was 28.1 kg/m2 at delivery, while the mean BMI was 30.3 kg/m2 (range 23–40) at delivery. Macrosomia was suspected in 80% on the basis of clinical examination, sonography, and the presence of the following risk factors in association: previous delivery of an infant weighing >4,000 g (62.5%), maternal weight at booking of more than 80 kg (90%), maternal BMI before delivery of ≥28 kg/m2 (50%), gestational diabetes mellitus (2.5%), and weight increase of more than 13 kg during pregnancy (5%). The mean birth weight of the babies was 4,750 g (4,500–5,000). The overall CS rate was 15%. The difference in the CS rate between these mothers and the control was not significant (P = 0.41). Only 9 (3.8%) mothers were successfully delivered with the aid of ventouse due to delayed second stage of labor. There was a significant difference in the complication rates between the mothers of large infants and the control (P < 0.001). Four maternal deaths were associated with macrosomia for a maternal mortality rate of 1667/100,000. Four infants had shoulder dystocia and associated injuries. The perinatal mortality rate was 112.5/1,000 births.

Conclusions

The higher the total body weight at birth, the higher the rate of macrosomia. Macrosomia had implications for high morbidity and mortality in the mothers and their infants. Delivery methods need to be evaluated. Caesarean section should be more readily used.
Literatur
1.
Zurück zum Zitat American College of Obstetricians and Gynecologist (ACOG) (1991) Fetal macrosomia. Technical bulletin 159, ACOG, Washington, DC American College of Obstetricians and Gynecologist (ACOG) (1991) Fetal macrosomia. Technical bulletin 159, ACOG, Washington, DC
2.
Zurück zum Zitat Spellacy WN, Miller S, Winegar A, Peterson PQ (1985) Macrosomia—maternal characteristics and infant complications. Obstet Gynecol 66:158–161PubMed Spellacy WN, Miller S, Winegar A, Peterson PQ (1985) Macrosomia—maternal characteristics and infant complications. Obstet Gynecol 66:158–161PubMed
3.
Zurück zum Zitat Parks DG, Ziel HK (1978) Macrosomia: a proposed indication for primary caesarean section. Obstet Gynaecol 52:407–409 Parks DG, Ziel HK (1978) Macrosomia: a proposed indication for primary caesarean section. Obstet Gynaecol 52:407–409
4.
Zurück zum Zitat Berard J, Dufour P, Vintier D, Subtil D, Vanderstichele S, Monnier JC et al (1998) Fetal Macrosomia: risk factors and outcome. A study of the outcome concerning 100 cases >4,500 g. Eur J Obstet Gynecol Reprod Biol 77:51–59PubMedCrossRef Berard J, Dufour P, Vintier D, Subtil D, Vanderstichele S, Monnier JC et al (1998) Fetal Macrosomia: risk factors and outcome. A study of the outcome concerning 100 cases >4,500 g. Eur J Obstet Gynecol Reprod Biol 77:51–59PubMedCrossRef
5.
Zurück zum Zitat Johar R, Rayburn W, Weir D, Eggert L (1998) Birth weights in term infants; a 50-year perspective. J Reprod Med 33:813–816 Johar R, Rayburn W, Weir D, Eggert L (1998) Birth weights in term infants; a 50-year perspective. J Reprod Med 33:813–816
6.
Zurück zum Zitat Mikulandra F, Stojnic F, Perisa M, Merlak I, Sikic D, Zenic N (1993) Fetal macrosomia, pregnancy and delivery. Zentralbl Gynakol 115(12):553–561PubMed Mikulandra F, Stojnic F, Perisa M, Merlak I, Sikic D, Zenic N (1993) Fetal macrosomia, pregnancy and delivery. Zentralbl Gynakol 115(12):553–561PubMed
7.
Zurück zum Zitat Megafu U, Ozumba BC (1988) Obstetric complications of macrosomic babies in African women. Int J. Gynecol Obstet 26(2):197–202CrossRef Megafu U, Ozumba BC (1988) Obstetric complications of macrosomic babies in African women. Int J. Gynecol Obstet 26(2):197–202CrossRef
8.
Zurück zum Zitat Posner AC, Friedman S, Posner LB (1955) The large fetus. A study of 547 cases. Obstet Gynecol 5:268–278PubMed Posner AC, Friedman S, Posner LB (1955) The large fetus. A study of 547 cases. Obstet Gynecol 5:268–278PubMed
9.
Zurück zum Zitat Lipscomb KR (1995) The outcome of Macrosomic infants weighing at least 4,500 g: Los Angeles County + University of Southern California experience. Obstet Gynecol 85:558–564PubMedCrossRef Lipscomb KR (1995) The outcome of Macrosomic infants weighing at least 4,500 g: Los Angeles County + University of Southern California experience. Obstet Gynecol 85:558–564PubMedCrossRef
10.
Zurück zum Zitat Nickel I, Hagacad WP, Wease WH (1966) Glucose tolerance and excessively large infant. A twelve year follow-up study. Am J Obstet Gynecol 94:62 Nickel I, Hagacad WP, Wease WH (1966) Glucose tolerance and excessively large infant. A twelve year follow-up study. Am J Obstet Gynecol 94:62
11.
Zurück zum Zitat Doc N, Mosberg H, Jagani N, Schulman H (1984) Complications in fetal macrosomia. NY State J Med 84:302–305 Doc N, Mosberg H, Jagani N, Schulman H (1984) Complications in fetal macrosomia. NY State J Med 84:302–305
12.
Zurück zum Zitat Modanlou HD, Dorchester WL, Throsian A, Freeman RK (1980) Macrosomia—maternal, fetal and neonatal implications. Obstet Gynecol 55:420–424PubMed Modanlou HD, Dorchester WL, Throsian A, Freeman RK (1980) Macrosomia—maternal, fetal and neonatal implications. Obstet Gynecol 55:420–424PubMed
13.
Zurück zum Zitat Boyd ME, Usher RH, McLean FH (1983) Fetal macrosomia: prediction, risks, proposed management. Obstet Gynecol 61:715PubMed Boyd ME, Usher RH, McLean FH (1983) Fetal macrosomia: prediction, risks, proposed management. Obstet Gynecol 61:715PubMed
Metadaten
Titel
Fetal macrosomia in African women: a study of 249 cases
verfasst von
C. I. Kamanu
S. Onwere
B. Chigbu
C. Aluka
O. Okoro
M. Obasi
Publikationsdatum
01.06.2009
Verlag
Springer-Verlag
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 6/2009
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-008-0780-7

Weitere Artikel der Ausgabe 6/2009

Archives of Gynecology and Obstetrics 6/2009 Zur Ausgabe

Hirsutismus bei PCOS: Laser- und Lichttherapien helfen

26.04.2024 Hirsutismus Nachrichten

Laser- und Lichtbehandlungen können bei Frauen mit polyzystischem Ovarialsyndrom (PCOS) den übermäßigen Haarwuchs verringern und das Wohlbefinden verbessern – bei alleiniger Anwendung oder in Kombination mit Medikamenten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

Bei RSV-Impfung vor 60. Lebensjahr über Off-Label-Gebrauch aufklären!

22.04.2024 DGIM 2024 Kongressbericht

Durch die Häufung nach der COVID-19-Pandemie sind Infektionen mit dem Respiratorischen Synzytial-Virus (RSV) in den Fokus gerückt. Fachgesellschaften empfehlen eine Impfung inzwischen nicht nur für Säuglinge und Kleinkinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.